Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
J Biol Chem. 2024 Feb;300(2):105638. doi: 10.1016/j.jbc.2024.105638. Epub 2024 Jan 8.
The inflammasome is a large multiprotein complex that assembles in the cell cytoplasm in response to stress or pathogenic infection. Its primary function is to defend the cell and promote the secretion of pro-inflammatory cytokines, including IL-1β and IL-18. Previous research has shown that in immortalized bone marrow-derived macrophages (iBMDMs) inflammasome assembly is dependent on the deacetylase HDAC6 and the aggresome processing pathway (APP), a cellular pathway involved in the disposal of misfolded proteins. Here we used primary BMDMs from mice in which HDAC6 is ablated or impaired and found that inflammasome activation was largely normal. We also used human peripheral blood mononuclear cells and monocyte cell lines expressing a synthetic protein blocking the HDAC6-ubiquitin interaction and impairing the APP and found that inflammasome activation was moderately affected. Finally, we used a novel HDAC6 degrader and showed that inflammasome activation was partially impaired in human macrophage cell lines with depleted HDAC6. Our results therefore show that HDAC6 importance in inflammasome activation is context-dependent.
炎症小体是一种大型多蛋白复合物,在细胞细胞质中响应应激或致病性感染而组装。它的主要功能是保护细胞并促进促炎细胞因子(包括 IL-1β和 IL-18)的分泌。先前的研究表明,在永生化骨髓来源的巨噬细胞(iBMDMs)中,炎症小体的组装依赖于去乙酰化酶 HDAC6 和聚集体加工途径(APP),这是一种涉及错误折叠蛋白处理的细胞途径。在这里,我们使用了从缺乏或受损 HDAC6 的小鼠的原代 BMDMs 中发现,炎症小体的激活基本上是正常的。我们还使用了表达一种合成蛋白的人外周血单核细胞和单核细胞系,该蛋白阻断了 HDAC6-泛素相互作用并损害了 APP,发现炎症小体的激活受到中度影响。最后,我们使用了一种新型的 HDAC6 降解剂,并表明在耗尽 HDAC6 的人巨噬细胞系中,炎症小体的激活部分受损。因此,我们的结果表明,HDAC6 在炎症小体激活中的重要性是上下文相关的。